Jackson v. Teva Pharmaceuticals USA, Inc. et al
Jennifer Jackson |
Teva Women's Health Inc doing business as Teva Women's Health LLC, Teva Pharmaceuticals USA Inc, Teva Women's Health LLC, The Cooper Companies Inc and Coopersurgical Inc |
1:2021cv01083 |
March 17, 2021 |
US District Court for the Northern District of Georgia |
Leigh Martin May |
Personal Inj. Prod. Liability |
28 U.S.C. § 1332 |
Plaintiff |
Docket Report
This docket was last retrieved on March 17, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 20 ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. The below are the orders entered after discussion of these issues at that conference. 1. Leadership structure: After the Court discussed issues concerning the leadership structure with all parties, the Court ORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to their requested leadership structure and team within 7 days of the date of this order. 2. Future status conferences: The Court will hold status conferences once a month. The next six conferences will take place on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021; Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. The Court will send out the zoom links prior to the conferences. The parties will submit a proposed consent agenda 3 business days prior to the conference. The parties will also confer as to the format for presenting issues that require additional explanation. When these are necessary, they should also be filed 3 business days before the conference. 3. Stay of responsive pleading obligations: The Court continues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initial order. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individual cases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motions will later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All parties are to docket future filings only in the MDL case. The case caption should indicate whether any filing applies to all cases or list the individual cases to which it should apply. 6. Electronic service: The Court ORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system. Because all attorneys will then receive electronic copies of documents filed in the MDL, the Court ORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation of service. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shall be obligated to provide service copies of any filings or related orders by U.S. Mail or any other means to attorneys who have not registered with the Court's CM/ECF system. An attorney who is not participating in the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or a certificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The Court GRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures; except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10, 2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8. Case management and initial orders: The parties are ORDERED to confer as to proposed orders for the list found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 2/10/2021.(tmf) |
Filing 19 ELEVENTH AMENDMENT TO GENERAL ORDER 20-01 RE: COURT OPERATIONS UNDER THE EXIGENT CIRCUMSTANCES CREATED BY COVID-19 AND RELATED CORONAVIRUS Signed by Judge Thomas W. Thrash, Jr. on 3/09/21. (aar) |
Filing 18 Case transferred in from District of New York Southern; Case Number 7:21-cv-01500. Original file certified copy of transfer order and docket sheet received. |
MDL TRANSFER OUT ELECTRONICALLY: to the United States District Court - Northern District of Georgia (sjo) [Transferred from New York Southern on 3/17/2021.] |
Civil Case Terminated. (tmf) |
Filing 17 CERTIFIED TRUE COPY OF CONDITIONAL MDL TRANSFER OUT ORDER FROM THE MDL PANEL...transferring this action from the U.S.D.C. - S.D.N.Y to the United States District Court - Northern District of Georgia. (Signed by MDL Panel on 3/16/2021) (sjo) [Transferred from New York Southern on 3/17/2021.] |
Filing 16 AFFIDAVIT OF SERVICE. Teva Women's Health, Inc. served on 2/26/2021, answer due 3/19/2021. Document filed by Jennifer Jackson..(Kassan, Randi) [Transferred from New York Southern on 3/17/2021.] |
Filing 15 AFFIDAVIT OF SERVICE. Teva Women's Health, LLC served on 2/26/2021, answer due 3/19/2021. Document filed by Jennifer Jackson..(Kassan, Randi) [Transferred from New York Southern on 3/17/2021.] |
Filing 14 AFFIDAVIT OF SERVICE. Teva Pharmaceuticals USA, Inc. served on 2/26/2021, answer due 3/19/2021. Document filed by Jennifer Jackson..(Kassan, Randi) [Transferred from New York Southern on 3/17/2021.] |
Filing 13 AFFIDAVIT OF SERVICE. CooperSurgical, Inc. served on 2/26/2021, answer due 3/19/2021. Document filed by Jennifer Jackson..(Kassan, Randi) [Transferred from New York Southern on 3/17/2021.] |
Filing 12 AFFIDAVIT OF SERVICE. The Cooper Companies, Inc. served on 2/26/2021, answer due 3/19/2021. Document filed by Jennifer Jackson..(Kassan, Randi) [Transferred from New York Southern on 3/17/2021.] |
Filing 11 ELECTRONIC SUMMONS ISSUED as to The Cooper Companies, Inc.. (sj) [Transferred from New York Southern on 3/17/2021.] |
Filing 10 ELECTRONIC SUMMONS ISSUED as to CooperSurgical, Inc.. (sj) [Transferred from New York Southern on 3/17/2021.] |
Filing 9 ELECTRONIC SUMMONS ISSUED as to Teva Women's Health, LLC. (sj) [Transferred from New York Southern on 3/17/2021.] |
Filing 8 ELECTRONIC SUMMONS ISSUED as to Teva Women's Health, Inc.. (sj) [Transferred from New York Southern on 3/17/2021.] |
Filing 7 ELECTRONIC SUMMONS ISSUED as to Teva Pharmaceuticals USA, Inc.. (sj) [Transferred from New York Southern on 3/17/2021.] |
***NOTICE TO ATTORNEY REGARDING PARTY MODIFICATION. Notice to attorney Randi Alyson Kassan. The party information for the following party/parties has been modified: Teva Women's Health, Inc.. The information for the party/parties has been modified for the following reason/reasons: party name was entered in all caps; alias party name was entered in all caps; alias party type was entered incorrectly. (sj) [Transferred from New York Southern on 3/17/2021.] |
CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is assigned to Judge Philip M. Halpern. Please download and review the Individual Practices of the assigned District Judge, located at #https://nysd.uscourts.gov/judges/district-judges. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. Please download and review the ECF Rules and Instructions, located at #https://nysd.uscourts.gov/rules/ecf-related-instructions..(sj) [Transferred from New York Southern on 3/17/2021.] |
***NOTICE TO ATTORNEY REGARDING DEFICIENT CIVIL COVER SHEET. Notice to attorney Randi Alyson Kassan to RE-FILE Document No. #1 Complaint. The filing is deficient for the following reason(s): the event wrong event type was used to file the civil cover sheet. Re-file the document using the event type Civil Cover Sheet found under the event list Other Documents and attach the correct PDF. (sj) [Transferred from New York Southern on 3/17/2021.] |
Magistrate Judge Paul E. Davison is so designated. Pursuant to 28 U.S.C. Section 636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed before a United States Magistrate Judge. Parties who wish to consent may access the necessary form at the following link: #https://nysd.uscourts.gov/sites/default/files/2018-06/AO-3.pdf. (sj) [Transferred from New York Southern on 3/17/2021.] |
Case Designated ECF. (sj) [Transferred from New York Southern on 3/17/2021.] |
Filing 6 REQUEST FOR ISSUANCE OF SUMMONS as to The Cooper Companies, Inc., re: #1 Complaint,. Document filed by Jennifer Jackson..(Kassan, Randi) [Transferred from New York Southern on 3/17/2021.] |
Filing 5 REQUEST FOR ISSUANCE OF SUMMONS as to CooperSurgical, Inc., re: #1 Complaint,. Document filed by Jennifer Jackson..(Kassan, Randi) [Transferred from New York Southern on 3/17/2021.] |
Filing 4 REQUEST FOR ISSUANCE OF SUMMONS as to Teva Women's Health, LLC, re: #1 Complaint,. Document filed by Jennifer Jackson..(Kassan, Randi) [Transferred from New York Southern on 3/17/2021.] |
Filing 3 REQUEST FOR ISSUANCE OF SUMMONS as to Teva Women's Health, Inc. d/b/a Teva Women's Health, LLC, re: #1 Complaint,. Document filed by Jennifer Jackson..(Kassan, Randi) [Transferred from New York Southern on 3/17/2021.] |
Filing 2 REQUEST FOR ISSUANCE OF SUMMONS as to Teva Pharmaceuticals USA, Inc., re: #1 Complaint,. Document filed by Jennifer Jackson..(Kassan, Randi) [Transferred from New York Southern on 3/17/2021.] |
Filing 1 COMPLAINT against CooperSurgical, Inc., TEVA WOMENS HEALTH, INC. d/b/a TEVA WOMENS HEALTH, LLC, Teva Pharmaceuticals USA, Inc., Teva Women's Health, LLC, The Cooper Companies, Inc.. (Filing Fee $ 402.00, Receipt Number ANYSDC-24003841)Document filed by Jennifer Jackson. (Attachments: #1 Civil Cover Sheet).(Kassan, Randi) [Transferred from New York Southern on 3/17/2021.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Georgia Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.